纤维化间质性肺病合并急性呼吸衰竭的机械通气与院内死亡预测因素:基于急性呼吸窘迫综合征范式的队列分析
回顾性队列研究纳入单中心多院区医疗ICU连续111例纤维化间质性肺病机械通气患者(共114次入院),特发性肺纤维化占34%,特发性急性加重为最常见入院类型(65%)。95%以容量控制通气启动,仅50%在插管3小时内达到低潮气量策略(平台压≤30 cm H2O)。校正后,早期达到目标平台压(OR 0.23;0.07-0.76;P=0.016)、3小时与48小时PaO2/FIO2较高、初始平均气道压较低与总净液体量较少与院内死亡风险降低相关。作者认为需进一步研究以完善可能改善生存的机械通气策略。
要点
- 仅50%的纤维化间质性肺病机械通气患者在插管3小时内达到平台压≤30 cm H2O的低潮气量策略。
- 校正后早期达到目标平台压与院内死亡风险降低相关(OR 0.23;95%CI 0.07-0.76;P=0.016)。
- 初始平均气道压每升高1个单位与院内死亡风险升高相关(OR 1.13;1.02-1.28;P=0.019)。
- 总净液体量每增加1 mL与院内死亡风险升高相关(OR 1.01;1.001-1.02;P=0.0001)。
- 3小时与48小时PaO2/FIO2较高均与院内死亡风险降低相关(OR 0.98;0.96-0.99;P=0.002 与 OR 0.98;0.97-0.99;P=0.018)。
适用人群与场景
- 单中心、多院区医疗ICU连续收治的纤维化间质性肺病因急性呼吸衰竭接受机械通气的患者,共111例、114次入院。
- 特发性肺纤维化占34%,特发性急性加重为最常见入院类型(65%)。
处置流程与药物剂量
- 95%以 mandatory volume-control ventilation 启动。
- 仅50%在插管3小时内达到低潮气量策略(平台压≤30 cm H2O)。
研究设计与关键结果
- 回顾性队列研究:111例纤维化间质性肺病机械通气患者共114次入院,分析基线特征与通气变量对院内死亡的预测作用。
- 未校正临床预测因素:年龄(单位OR 1.05;1.01-1.10;P=0.015)、入院至插管时间(小时)(单位OR 1.01;1.01-1.03;P=0.017)、使用肌松药(RR 1.54;1.26-1.90;P<0.001)。
- 校正后机械通气相关预测因素:早期达到目标平台压(OR 0.23;0.07-0.76;P=0.016)、3小时PaO2/FIO2(单位OR 0.98;0.96-0.99;P=0.002)、48小时PaO2/FIO2(单位OR 0.98;0.97-0.99;P=0.018)、初始平均气道压(单位OR 1.13;1.02-1.28;P=0.019)、总净液体量(mL)(单位OR 1.01;1.001-1.02;P=0.0001)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,从ARDS范式审视纤维化间质性肺病机械通气,早期达到目标平台压、较低初始平均气道压、较低总净液体量与较好氧合可能与院内死亡风险降低相关。
- 作者结论指出需进一步研究以完善可能改善该组患者生存的机械通气策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Prior studies report significant mortality in fibrotic interstitial lung disease patients undergoing mechanical ventilation. Little is known about baseline characteristics or ventilator strategies that might improve outcomes. We analyzed the ventilator characteristics of a large cohort of fibrotic interstitial lung disease patients from the perspective of an acute respiratory distress syndrome paradigm to see if any specific mechanical ventilation strategies might improve in-hospital mortality.
DESIGN: Retrospective cohort study.
SETTING: Single-center, multihospital medical ICUs.
PATIENTS: Consecutive fibrotic interstitial lung disease patients who experienced mechanical ventilation for acute respiratory failure.
INTERVENTIONS: Interstitial lung disease characteristics, demographics, and ventilator variables were analyzed for univariable and multivariable predictors of in-hospital mortality, adjusted for confounding with an a priori causation model.
MEASUREMENTS AND MAIN RESULTS: A total of 111 patients accounted for 114 admissions. Idiopathic pulmonary fibrosis comprised 34% with idiopathic acute exacerbation (65%) being the most common admission type. Ninety-five percent were initiated on mandatory volume-control ventilation with only 50% achieving a low tidal volume strategy (plateau pressure ≤ 30 cm H2O) within 3 hours of intubation. Unadjusted clinical predictors of in-hospital mortality included age (unit odds ratio, 1.05; 1.01-1.10; p = 0.015), time from admission to intubation (hr) (unit odds ratio, 1.01; 1.01-1.03; p = 0.017), and use of paralytics (relative risk, 1.54; 1.26-1.90, p < 0.001). Adjusted mechanical ventilation-related predictors of in-hospital mortality included achieving early targeted plateau pressures (odds ratio, 0.23; 0.07-0.76; p = 0.016), PaO2/FIO2 ratio at 3 (unit odds ratio, 0.98; 0.96-0.99, p = 0.002) and 48 hours (unit odds ratio, 0.98; 0.97-0.99, p = 0.018), initial mean airway pressure (unit odds ratio, 1.13; 1.02-1.28, p = 0.019), and total net fluid status (mL) (unit odds ratio, 1.01; 1.001-1.02, p = 0.0001).
CONCLUSIONS: Several factors predict in-hospital mortality in fibrotic interstitial lung disease-associated mechanical ventilation when viewed through an acute respiratory distress syndrome model. Further research is needed to refine strategies that may perhaps improve survival if mechanical ventilation is pursued in this set of patients.
参考来源
- Martin MJ, Moua T. Mechanical Ventilation and Predictors of In-Hospital Mortality in Fibrotic Interstitial Lung Disease With Acute Respiratory Failure: A Cohort Analysis Through the Paradigm of Acute Respiratory Distress Syndrome. Crit Care Med. 2020. PMID: 32355133. doi:10.1097/CCM.0000000000004366
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。